Biogen Inc. buy Needham & Company LLC
Start price
13.02.24
/
50%
€220.60
Target price
13.02.25
€284.87
Performance (%)
-39.60%
End price
14.02.25
€133.25
Summary
This prediction ended on 14.02.25 with a price of €133.25. The BUY prediction by Needham___Company_LL for Biogen Inc. performed very badly with a performance of -39.60%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 1.079% | 1.079% | 57.242% |
| iShares Core DAX® | 0,42 % | 5,71 % | 4,70 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % | 38,95 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % | 50,39 % |
| iShares S&P 500 | 1,79 % | 9,64 % | 26,90 % |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $305.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten